{"id":775169,"date":"2023-08-03T15:28:47","date_gmt":"2023-08-03T19:28:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/"},"modified":"2023-08-03T15:28:47","modified_gmt":"2023-08-03T19:28:47","slug":"mustang-bio-to-participate-in-two-august-2023-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/","title":{"rendered":"Mustang Bio to Participate in Two August 2023 Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">WORCESTER, Mass., Aug.  03, 2023  (GLOBE NEWSWIRE) &#8212; Mustang Bio, Inc. (\u201cMustang\u201d) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today\u2019s medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and rare genetic diseases, today announced that Manuel Litchman, M.D., President and Chief Executive Officer, will participate in two investor conferences in August 2023.<\/p>\n<p>Details of the events are as follows:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>BTIG Virtual Biotechnology Conference 2023:<\/strong> The company will present a corporate update on Tuesday, August 8, 2023, at 9:00 a.m. ET and will participate in one-on-one meetings during the conference. For more information or to join the conference, email\u00a0<a href=\"mailto:info@btig.com\" rel=\"nofollow noopener\" target=\"_blank\">info@btig.com<\/a>.<\/li>\n<li style=\"text-align:justify\">\n          <strong>H.C. Wainwright\u00a0Immune Cell Engager Virtual Conference:<\/strong> The company will participate in a fireside chat on Thursday, August 17, 2023, at 3:00 p.m. ET and will attend one-on-one meetings during the conference. A webcast of the company\u2019s fireside chat will be available on the News &amp; Events page of the Investor Relations section of Mustang\u2019s website, <a href=\"http:\/\/www.mustangbio.com\" rel=\"nofollow noopener\" target=\"_blank\">www.mustangbio.com<\/a>, for approximately 30 days after the conference.<\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>About Mustang Bio<\/strong><br \/>\n        <br \/>Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating today\u2019s medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and rare genetic diseases. Mustang aims to acquire rights to these technologies by licensing or otherwise acquiring an ownership interest, to fund research and development, and to outlicense or bring the technologies to market. Mustang has partnered with top medical institutions to advance the development of CAR-T therapies across multiple cancers, as well as lentiviral gene therapies for severe combined immunodeficiency. Mustang\u2019s common stock is registered under the Securities Exchange Act of 1934, as amended, and Mustang files periodic reports with the U.S. Securities and Exchange Commission (\u201cSEC\u201d). Mustang was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-VRfjgp8HR0dbj_AvKMqT_lgpGODj8CjLvzeYprgeeAxPL6iHhO1tMruPOE4Ah6G74sZ7wtOBeMywAV8tv4t42Xj8NU0D9gD7TdZyYoe_Ik=\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.mustangbio.com<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Forward\u2010Looking Statements<br \/><\/strong>This press release contains \u201cforward-looking statements\u201d within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Such statements, which are often indicated by terms such as \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cgoal,\u201d \u201cintend,\u201d \u201clook forward to,\u201d \u201cmay,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cshould,\u201d \u201cwill,\u201d \u201cwould\u201d and similar expressions. The Company\u2019s forward-looking statements, include, but are not limited to, any statements relating to our growth strategy and product development programs, including the timing of and our ability to make regulatory filings such as INDs and other applications and to obtain regulatory approvals for our product candidates, statements concerning the potential of therapies and product candidates and any other statements that are not historical facts. Actual events or results may differ materially from those described in this press release due to a number of risks and uncertainties. Risks and uncertainties include, among other things, risks related to whether Company\u2019s third-party manufacturer is able to successfully perform its obligation to produce the Company\u2019s products under the manufacturing services agreement on a timely basis and to acceptable standards; disruption from the sale of the Company\u2019s manufacturing facility making it more difficult to maintain business and operational relationships; negative effects of the announcement of the consummation of the sale of the Company\u2019s manufacturing facility on the market price of the Company\u2019s common stock; significant transaction costs; the development stage of the Company\u2019s primary product candidates, our ability to obtain, perform under, and maintain financing and strategic agreements and relationships; risks relating to the results of research and development activities; risks relating to the timing of starting and completing clinical trials; uncertainties relating to preclinical and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in Part I, Item 1A, \u201cRisk Factors,\u201d in our Annual Report on Form 10-K filed on March 30, 2023, subsequent Reports on Form 10-Q, and our other filings we make with the SEC. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law, and we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.<\/p>\n<p>\n        <strong>Company Contact:<\/strong><br \/>\n        <br \/>Jaclyn Jaffe<br \/>Mustang Bio, Inc.<br \/>(781) 652-4500<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=X6oB6t-0JfSF697kPs95WDTPm3xlyXLcHHbaH1Q3_clnn0is3XQTeDEFt0KbXif_20PqhvY8uRVjjqhNGRU7ywq8j_9OBBVekqaL8wqrYQ0=\" rel=\"nofollow noopener\" target=\"_blank\">ir@mustangbio.com<\/a><\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Daniel Ferry<br \/>LifeSci Advisors, LLC<br \/>(617) 430-7576<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qMx-351eN8eaJb6XHz4sT29jRrzHH47DTpqgRegzataxuSYnKed94sPD3Ckps4BVSfQ5QEah10KDAwdaIpnjkn9KpngubtTdQ1t-ttWnuhPaJzB0K_BVl8urVxSB7NZ1\" rel=\"nofollow noopener\" target=\"_blank\">daniel@lifesciadvisors.com<\/a><\/p>\n<p>\n        <strong>Media Relations Contact:<\/strong><br \/>\n        <br \/>Tony Plohoros<br \/>6 Degrees<br \/>(908) 591-2839<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iyzbBMIijNAHT-IKo2YHw0IXl6_M_8Fs-Ir3aVP508ckL7a2Uj3MPXHeTp6e8yw7STcy6CrVtDkJmy_6AW3SUWnhi5sRDLEi65WDsVRFnb4=\" rel=\"nofollow noopener\" target=\"_blank\">tplohoros@6degreespr.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjMzMSM1NzMzODExIzIwNDk3NTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MmMxOWZjZjgtNmE2ZS00ZjRjLTk4MDgtZDU2MjA0MDBlZTg5LTEwNjEzMjg=\/tiny\/Mustang-Bio-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WORCESTER, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) &#8212; Mustang Bio, Inc. (\u201cMustang\u201d) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today\u2019s medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and rare genetic diseases, today announced that Manuel Litchman, M.D., President and Chief Executive Officer, will participate in two investor conferences in August 2023. Details of the events are as follows: BTIG Virtual Biotechnology Conference 2023: The company will present a corporate update on Tuesday, August 8, 2023, at 9:00 a.m. ET and will participate in one-on-one meetings during the conference. For more information or to join the conference, email\u00a0info@btig.com. H.C. Wainwright\u00a0Immune Cell Engager Virtual Conference: The company will participate in a fireside chat on &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Mustang Bio to Participate in Two August 2023 Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-775169","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mustang Bio to Participate in Two August 2023 Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mustang Bio to Participate in Two August 2023 Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WORCESTER, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) &#8212; Mustang Bio, Inc. (\u201cMustang\u201d) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today\u2019s medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and rare genetic diseases, today announced that Manuel Litchman, M.D., President and Chief Executive Officer, will participate in two investor conferences in August 2023. Details of the events are as follows: BTIG Virtual Biotechnology Conference 2023: The company will present a corporate update on Tuesday, August 8, 2023, at 9:00 a.m. ET and will participate in one-on-one meetings during the conference. For more information or to join the conference, email\u00a0info@btig.com. H.C. Wainwright\u00a0Immune Cell Engager Virtual Conference: The company will participate in a fireside chat on &hellip; Continue reading &quot;Mustang Bio to Participate in Two August 2023 Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-03T19:28:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjMzMSM1NzMzODExIzIwNDk3NTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Mustang Bio to Participate in Two August 2023 Investor Conferences\",\"datePublished\":\"2023-08-03T19:28:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\\\/\"},\"wordCount\":778,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NjMzMSM1NzMzODExIzIwNDk3NTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\\\/\",\"name\":\"Mustang Bio to Participate in Two August 2023 Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NjMzMSM1NzMzODExIzIwNDk3NTc=\",\"datePublished\":\"2023-08-03T19:28:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NjMzMSM1NzMzODExIzIwNDk3NTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NjMzMSM1NzMzODExIzIwNDk3NTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mustang Bio to Participate in Two August 2023 Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mustang Bio to Participate in Two August 2023 Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Mustang Bio to Participate in Two August 2023 Investor Conferences - Market Newsdesk","og_description":"WORCESTER, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) &#8212; Mustang Bio, Inc. (\u201cMustang\u201d) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today\u2019s medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and rare genetic diseases, today announced that Manuel Litchman, M.D., President and Chief Executive Officer, will participate in two investor conferences in August 2023. Details of the events are as follows: BTIG Virtual Biotechnology Conference 2023: The company will present a corporate update on Tuesday, August 8, 2023, at 9:00 a.m. ET and will participate in one-on-one meetings during the conference. For more information or to join the conference, email\u00a0info@btig.com. H.C. Wainwright\u00a0Immune Cell Engager Virtual Conference: The company will participate in a fireside chat on &hellip; Continue reading \"Mustang Bio to Participate in Two August 2023 Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-03T19:28:47+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjMzMSM1NzMzODExIzIwNDk3NTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Mustang Bio to Participate in Two August 2023 Investor Conferences","datePublished":"2023-08-03T19:28:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/"},"wordCount":778,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjMzMSM1NzMzODExIzIwNDk3NTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/","name":"Mustang Bio to Participate in Two August 2023 Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjMzMSM1NzMzODExIzIwNDk3NTc=","datePublished":"2023-08-03T19:28:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjMzMSM1NzMzODExIzIwNDk3NTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjMzMSM1NzMzODExIzIwNDk3NTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mustang-bio-to-participate-in-two-august-2023-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Mustang Bio to Participate in Two August 2023 Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/775169","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=775169"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/775169\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=775169"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=775169"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=775169"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}